— Know what they know.
/
Not Investment Advice

CL

NYSE · USD
Colgate-Palmolive Company
Consumer Defensive · Household & Personal Products
CEO Noel R. Wallace Employees 33,600 R&D / revenue 0.0%
Last price
$94.11+1.55%last session
Market cap
$75.0B
P/E (TTM)
37.0x
From 52w high
−5.3%
From 52w low
+26.2%
1-year return
+21.3%
RSI 14 · vs SMA200
73.1 · +5.8%
IS score
60.5/ 100
Factor model across 8 sub-scores, ranked against 3,010 US stocks. Describes the business, not the outlook.
Download full factsheet (PDF)

One year, rebased to 100

CL   SPY   XLP (sector ETF) · weekly closes
100110120Jan 26Apr 26Jul 26Oct 26CL 121SPY 116XLP 111

Score DNA

Each bar is a 0-100 score within the scored universe
72
Profitability
49
Growth
39
Value
58
Momentum
100
Risk (safety)
64
Quality
46
Balance sheet
62
Earnings quality

Flags

Strengths
✓ Piotroski 8+✓ FCF yield 5%+✓ Congress buying
Warnings
None of the computed warning flags fires for CL (Altman, Beneish, accruals, FCF, dilution).
Observations
Moat model: Narrow, Cost AdvantagePiotroski 8 / 9Altman Z 6.9Beta 0.323 of 4 smart-money sources active

Smart-money strip

Each disclosure source on its own window. Filings coinciding is not coordination.
INSForm 4 · 180 days
Insider open-market buys
0
6 open-market sales, $32.0M
Form 144 notices (12m): 11, $53.5M proposed, not confirmed sales
CONGSTOCK Act · 180 days
Congressional purchases
1
Last disclosed purchase 2026-06-02
Members disclose in ranges, 30-45 days after the trade
13F13F · quarter to 2026-06-30
Net change in institutional holders
+67
193 new holders, 101 closed
2,032 filers hold 84.8% · 732 added, 734 trimmed
ETFETF holdings · 30 days
Net funds accumulating
+258
1,229 funds adding shares
971 funds trimming · counts of funds, not dollars
DARKFINRA · daily
Short-sale share of off-exchange volume
61.5%
20-day avg 59.3%, 50-day avg 52.1%
Latest 2.2 pp over its 20-day average · a flow, not short interest

Key financials · FY2025

USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.
Income statement
Revenue$20.4B
Revenue growth YoY+1.4%
Gross margin60.1%
Operating income$4.3B
Operating margin21.3%
Net income$2.1B
Net margin10.5%
EPS (diluted)$2.63
Cash flow
Operating cash flow$4.2B
Capital expenditure$564.0M
Free cash flow$3.6B
FCF conversion (FCF / OCF)86.6%
Stock-based compensation$0
FCF less SBC$3.6B
Buybacks$1.2B
Dividends$1.8B
Balance sheet & returns
Cash & short-term investments$1.3B
Total debt$8.0B
Net debt$6.7B
Shareholders' equity$365.0M
Goodwill & intangibles$4.7B
Debt / equity33.29
ROE (TTM)631.1%
ROIC (TTM)29.9%
Operating margin by fiscal year
22.8%FY202120.8%FY202221.6%FY202322.6%FY202421.3%FY2025
Revenue $17.4B (FY2021) to $20.4B (FY2025), a 4.0% CAGR.

Valuation

P/E (TTM)37.0x
EV / EBITDA21.2x
Price / sales3.56x
Price / FCF19.4x
FCF yield5.14%
Buyback yield1.61%
SBC / revenue0.5%
Price / book317.64x
Forward P/E FY202624.4x
Forward P/E FY202723.0x
Forward P/E FY202821.5x
Forward multiples divide today's price by Street EPS estimates. Street mean target $103.17 across 6 analysts last quarter is theirs, not ours.

CL vs industry median

112 companies in Household & Personal Products
Gross margin 60.4% 49.5% Operating margin 20.7% 4.8% Net margin 9.7% 0.4% ROIC 29.9% 10.5%
CL (TTM)Industry median Asset turnover 1.25 vs industry 0.81 · financial leverage 71.14

Earnings delivery

Next report 2026-10-30 · consensus EPS $0.93
100%
beat rate, 12 of 12 quarters
+3.5%
median EPS surprise
12
longest beat streak
+7+2+6+5+2+1+6+3+2+4+3+5
EPS surprise in % vs the consensus at the time, oldest (left) to newest, 2023-10-27 to 2026-07-31. Bars cap at ±60%.

Peers

Market-cap band, not the industry cohort above
CompanyMkt capP/EROENet marginRev growth12m return
CL Colgate-Palmolive Company $75.0B37.0x631.1%9.7%+1.4% +21.3%
EL The Estée Lauder Companies $37.9B205.0x4.7%-3.2%+5.1% +8.4%
KVUE Kenvue Inc. $36.3B21.7x15.6%11.5%+1.8% +35.7%
KMB Kimberly-Clark Corporation $35.1B18.0x129.4%8.2%−12.3% −11.8%
CHD Church & Dwight Co., Inc. $24.8B33.5x17.0%13.3%+2.7% +21.4%
PG The Procter & Gamble Company $370.0B23.6x30.2%14.1%+3.3% —
CLX The Clorox Company $10.5B18.1x285.6%8.4%−5.4% —
TGT Target Corporation $70.1B15.9x26.4%7.1%+2.0% —
12-month window: SPY +15.9%, sector ETF XLP +11.4%. Past returns describe history only.

Recent 8-K filings

2026-07-31Earnings Release; Exhibits
2026-05-13Shareholder Vote
2026-05-01Earnings Release; Exit/Disposal Costs; Exhibits
2026-04-09Officer/Director Change
2026-03-17Other Events; Financial Statements and Exhibits
2026-03-12Departure/Election of Directors; Appointment of Officers

Context

Shares outstanding797,173,000
Free float93.9%
Institutional ownership84.8%
Beta0.32
Dividend yield2.23%
Last dividend$0.53 on 2026-10-20
50 / 200-day average$89.13 / $88.92
Large-cap Consumer Defensive median P/E23.3x

Full factsheet

The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (Narrow).

Read it in the browser Download (PDF)

All fundamentals · 140 measures in 13 categories

Percentile = where CL sits among 20 scored companies in Household & Personal Products (0 = lowest value, 100 = highest). It is a position, not a grade.
ValuationProfitability (TTM)Returns on capitalGrowthMargin history & stabilityLiquidity (latest quarter)Leverage & solvency (latest quarter)EfficiencyCash flow & earnings qualityDividends & buybacksScores & forensic checksPer shareSize (TTM)

Valuation

MeasureCLIndustry medianIndustry percentileSector median
P/E (TTM) 36.8x 22.9x
73rd		 20.0x
PEG (P/E ÷ 3-yr EPS CAGR) 3.08 2.19
71st		 1.14
Price / sales 3.6x 2.0x
84th		 1.1x
Price / book 317.9x 3.8x
100th		 2.5x
Price / tangible book —
Price / free cash flow 19.4x 17.2x
56th		 14.7x
Price / operating cash flow 16.8x 10.6x
69th		 9.4x
Enterprise value $81.5B $6.2B
95th		 $5.1B
EV / sales 3.9x 2.2x
84th		 1.3x
EV / EBITDA 21.2x 16.2x
69th		 12.3x
EV / EBIT 25.5x 25.5x
50th		 16.5x
EV / free cash flow 21.1x 20.6x
56th		 18.2x
Earnings yield 2.7% 1.0%
58th		 3.9%
FCF yield 5.1% 5.0%
53rd		 6.5%
Operating cash flow yield 5.9% 6.7%
42nd		 10.4%
Graham number (per share) $4.08 $20.47
0th		 $35.68

Profitability (TTM)

MeasureCLIndustry medianIndustry percentileSector median
Gross margin 60.4% 48.8%
68th		 34.4%
EBITDA margin 18.2% 11.0%
74th		 10.7%
Operating margin 20.7% 9.4%
89th		 7.6%
EBIT margin 15.2% 6.5%
79th		 6.9%
Net margin 9.7% 2.5%
74th		 3.3%
NOPAT margin 15.2% 6.9%
89th		 4.8%
FCF margin 18.3% 8.6%
100th		 7.6%
Operating cash flow margin 21.2% 11.7%
95th		 11.1%
R&D / revenue 0.0% 0.0%
0th		 0.0%
SG&A / revenue 39.3% 29.8%
63rd		 21.1%
Stock comp / revenue 0.5% 0.9%
28th		 0.5%
Effective tax rate 26.5% 21.4%
79th		 23.2%

Returns on capital

MeasureCLIndustry medianIndustry percentileSector median
ROE (on average equity) 434.3% 4.9%
100th		 10.4%
ROA 11.9% 1.9%
95th		 4.9%
ROIC 47.5% 10.5%
89th		 8.2%
ROCE 30.0% 6.2%
100th		 9.1%
Return on tangible assets 18.7% 5.2%
100th		 7.2%
Cash ROIC (OCF / invested capital) 66.3% 13.6%
94th		 15.0%
Gross profitability (GP / assets) 75.7% 35.5%
100th		 32.4%
ROIC, 3-yr average 35.0% 7.8%
100th		 6.4%
ROIC, 5-yr average —
ROE, 5-yr average —
Incremental ROIC -77.2% -27.2%
42nd		 12.8%

Growth

MeasureCLIndustry medianIndustry percentileSector median
Revenue growth (TTM YoY) 5.2% 2.2%
79th		 3.8%
Revenue growth (QoQ) 0.7% 6.5%
32nd		 4.3%
Revenue CAGR, 3 yr 4.1% 1.5%
67th		 3.8%
Revenue CAGR, 5 yr 4.3% 2.6%
60th		 5.1%
Gross profit CAGR, 3 yr 6.2% 5.6%
56th		 4.0%
Operating income CAGR, 3 yr 4.2% 3.6%
58th		 4.3%
Net income growth (TTM YoY) -30.0% 0.5%
20th		 5.6%
Net income CAGR, 3 yr 10.8% 6.0%
60th		 5.4%
EPS growth (TTM YoY) -29.0% 1.8%
20th		 4.7%
EPS CAGR, 3 yr 12.0% 6.6%
60th		 6.8%
EPS CAGR, 5 yr -4.7% -1.3%
11th		 4.1%
FCF growth (TTM YoY) 14.5% 24.1%
23rd		 23.4%
FCF CAGR, 3 yr 17.9% 6.5%
69th		 14.6%
Operating cash flow CAGR, 3 yr 12.9% 5.2%
64th		 6.4%
Book value CAGR, 3 yr —
Dividend CAGR, 3 yr 1.4% 1.2%
67th		 1.7%
Sustainable growth rate 45.8% 7.2%
100th		 8.3%

Margin history & stability

MeasureCLIndustry medianIndustry percentileSector median
Gross margin, 3-yr average 60.2% 49.2%
74th		 34.7%
Operating margin, 3-yr average 21.7% 8.6%
95th		 6.7%
Net margin, 3-yr average 12.8% 5.1%
95th		 4.2%
FCF margin, 3-yr average 17.3% 7.4%
95th		 6.5%
Revenue stability (0-1) 0.97 0.71
95th		 0.81
Earnings stability (0-1) 0.01 0.39
5th		 0.34
Margin stability (0-1) 0.97 0.95
79th		 0.95

Liquidity (latest quarter)

MeasureCLIndustry medianIndustry percentileSector median
Cash & short-term investments $1.4B $243.9M
89th		 $279.3M
Net cash (− = net debt) −$6.5B −$1.6B
11th		 −$1.0B
Working capital $160.0M $236.0M
42nd		 $285.9M
Current ratio 1.03 1.72
26th		 1.43
Quick ratio 0.67 0.82
21st		 0.86
Cash ratio (cash + ST investments / current liabilities) 0.22 0.34
42nd		 0.28
Defensive interval (days) 145 days 251 days
5th		 251 days

Leverage & solvency (latest quarter)

MeasureCLIndustry medianIndustry percentileSector median
Total debt $7.9B $1.8B
84th		 $1.8B
Debt / equity 33.29 0.83
95th		 0.75
Net debt / equity 27.49 0.69
95th		 0.55
Debt / assets 46.8% 34.2%
79th		 31.6%
Debt / capital 97.1% 45.2%
95th		 43.0%
Debt / EBITDA 2.05 4.15
19th		 2.69
Net debt / EBITDA 1.69 2.60
19th		 2.14
Interest coverage (EBIT / interest) 12.5x 2.8x
83rd		 4.7x
Cash interest coverage 17.5x 6.2x
83rd		 8.2x
Debt payback (years of OCF) 1.8 yrs 3.3 yrs
19th		 2.8 yrs
Liabilities / assets 96.6% 59.0%
95th		 56.2%
IS credit model rating A+ — —
Implied credit spread (bps) 125 312
16th		 225

Efficiency

MeasureCLIndustry medianIndustry percentileSector median
Asset turnover 1.23 0.81
95th		 0.94
Fixed asset turnover 4.54 6.92
39th		 4.44
Inventory turnover 3.9 3.6
58th		 6.0
Receivables turnover 11.3 10.0
74th		 12.1
Days sales outstanding 32 days 36 days
26th		 30 days
Days inventory outstanding 94 days 103 days
42nd		 61 days
Days payables outstanding 86 days 78 days
58th		 38 days
Cash conversion cycle (days) 41 days 59 days
32nd		 37 days
Capex / revenue 2.8% 2.6%
53rd		 3.1%
Capex / depreciation 0.93 0.63
76th		 0.92
Operating expense ratio 42.5% 40.5%
56th		 24.8%

Cash flow & earnings quality

MeasureCLIndustry medianIndustry percentileSector median
Operating cash flow / net income 2.19 1.61
73rd		 1.87
FCF / net income 1.89 1.39
73rd		 1.28
FCF / operating cash flow 86.6% 78.2%
62nd		 71.9%
Capex / operating cash flow 13.4% 21.8%
38th		 29.5%
Accruals ratio -14.1% -6.2%
5th		 -6.1%
Sloan accruals ratio 1.7% -2.4%
84th		 -3.9%
Earnings quality score (0-1) 0.75 0.75
9th		 0.75

Dividends & buybacks

MeasureCLIndustry medianIndustry percentileSector median
Dividend yield 2.2% 1.7%
58th		 1.8%
Dividend per share (TTM) $2.10 $0.76
79th		 $0.64
Payout ratio (dividends / net income) 89.4% 58.4%
82nd		 32.1%
Dividends / FCF 47.2% 38.6%
62nd		 27.4%
Dividend growth (YoY) 2.4% 0.3%
69th		 1.8%
Buyback yield 0.6% 0.9%
47th		 0.9%
Shareholder yield (dividends + buybacks) 3.1% 3.6%
32nd		 3.6%
Share count change (YoY) -1.3% -0.1%
21st		 -0.2%
Buybacks, last 5 years $3.0B $184.1M
89th		 $184.1M

Scores & forensic checks

MeasureCLIndustry medianIndustry percentileSector median
IS score 61 47
79th		 53
IS profitability 72 31
100th		 32
IS growth 49 47
53rd		 50
IS value 39 46
26th		 49
IS momentum 58 62
47th		 73
IS risk (safety) 100 65
84th		 80
IS quality 64 55
63rd		 65
IS balance sheet 46 45
53rd		 53
IS earnings quality 62 66
42nd		 76
IS cash flow 72 59
84th		 57
Piotroski F-score (0-9) 8 6
79th		 6
Altman Z-score 6.9 2.8
95th		 3.2
Beneish M-score −3.14 −2.83
16th		 −2.71
Ohlson O-score −5.71 −6.65
79th		 −7.61
IS credit score 77 55
84th		 64

Per share

MeasureCLIndustry medianIndustry percentileSector median
EPS, diluted (TTM) $2.53 $0.68
68th		 $2.03
Book value per share $0.29 $8.09
0th		 $16.28
Tangible book per share −$5.06 −$2.96
26th		 $3.52
Revenue per share $26.12 $27.83
42nd		 $41.08
FCF per share $4.79 $3.23
74th		 $3.18
Operating cash flow per share $5.53 $4.84
74th		 $4.93
Cash per share $1.70 $3.22
42nd		 $2.81

Size (TTM)

MeasureCLIndustry medianIndustry percentileSector median
Market cap $75.0B $3.3B
95th		 $4.0B
Revenue $21.0B $3.5B
95th		 $5.2B
EBITDA $3.8B $305.7M
95th		 $426.9M
Net income $2.0B $69.7M
95th		 $167.0M
Free cash flow $3.9B $285.9M
95th		 $345.6M
Total assets $16.8B $4.5B
79th		 $4.8B
Shareholders' equity $236.0M $1.3B
21st		 $1.6B
Employees 33,600 6,350
84th		 9,700

Insider transactions, last 6 months

Form 4 · most recent 12
DateInsiderTypeSharesPriceValueOwned after
2026-10-01Norrington Lorrie M
Director
 Award / grant 300$87.42$26,22643,310
2026-10-01Newman Brian
Director
 Award / grant 214$87.42$18,7088,058
2026-10-01Bilbrey John P
Director
 Award / grant 271$87.42$23,69140,725
2026-09-16Wallace Noel R.
Director, Chairman, President & CEO
 Award / grant 29,649——379,700
2026-09-16Wallace Noel R.
Director, Chairman, President & CEO
 Award / grant 205,197$87.02$17.9M205,197
2026-09-16Grant Shane
COO, Americas
 Award / grant 7,355——79,503
2026-09-16Grant Shane
COO, Americas
 Award / grant 50,902$87.02$4.4M50,902
2026-09-16Tsourapas Panagiotis
COO, CD, EMEA, APac, Skin
 Award / grant 4,597——11,447
2026-09-16Tsourapas Panagiotis
COO, CD, EMEA, APac, Skin
 Award / grant 31,814$87.02$2.8M31,814
2026-09-16Sutula Stanley J Iii
Chief Financial Officer
 Award / grant 8,045——79,029
2026-09-16Sutula Stanley J Iii
Chief Financial Officer
 Award / grant 55,674$87.02$4.8M55,674
2026-09-16Hazlin John
Chief Growth Officer
 Award / grant 3,908——27,021

Shares acquired vs disposed, by month

acquired disposed · all Form 4 types
MarAprMayJunJulAugSepOct

By transaction type, 6 months

TypeDirectionFilingsSharesValue
Award / grantAcquired40517,045$38.2M
Open-market saleDisposed6347,111$32.0M
Option exerciseDisposed3326,212$23.6M
Option exerciseAcquired2165,191$11.9M
Tax withholdingDisposed2347,314$4.2M
—Disposed861,808$5.0M
Awards, option exercises and tax withholding are compensation mechanics; open-market buys and sales are the discretionary ones.

Form 144 notices

12 months: 11 notices · 574,374 shares · $53.5M
FiledFilerShares proposedEst. proceeds
2026-08-24Tsourapas Panagiotis10,000$920,477
2026-08-06Cahill John T4,170$389,358
2026-08-05Wallace Noel R.161,021$14.9M
2026-08-04Wallace Noel R.161,021$14.8M
A Form 144 is notice of a proposed sale, not a confirmed one.

Congress trades

12 months: House 16 trades (2 purchases) · Senate 0 (0 purchases)
TradedMemberChamberTypeAmountDisclosed
2026-09-11Ro KhannaHouseSale$1,001 - $15,0002026-10-09
2026-09-02Kevin HernHouseSale$1,001 - $15,0002026-09-28
2026-09-02Kevin HernHouseSale$1,001 - $15,0002026-09-25
2026-09-02Kevin HernHouseSale (Partial)$1,001 - $15,0002026-09-25
2025-10-09John BoozmanSenateSale$1,001 - $15,0002025-11-15
2025-07-31Shelley Moore CapitoSenateSale$1,001 - $15,0002025-08-04
2025-07-31Shelley Moore CapitoSenateSale (Full)$1,001 - $15,0002025-08-04
2025-07-31Shelley Moore CapitoSenateSale$1,001 - $15,0002025-08-04
STOCK Act disclosures, in ranges, filed up to 45 days after the trade.

Largest 13F holders

Quarter to 2026-06-30, the latest most managers have filed
ManagerSharesValue% of shares out
BlackRock, Inc.69,915,472$6.4B8.77%
VANGUARD CAPITAL MANAGEMENT LLC52,246,333$4.8B6.55%
STATE STREET CORP47,020,966$4.3B5.90%
PRICE T ROWE ASSOCIATES INC /MD/27,909,525$2.6B3.50%
VANGUARD PORTFOLIO MANAGEMENT LLC24,021,137$2.2B3.01%
GEODE CAPITAL MANAGEMENT, LLC23,144,319$2.1B2.90%
MORGAN STANLEY20,996,194$1.9B2.63%
Bank of New York Mellon Corp13,426,680$1.2B1.68%
DEUTSCHE BANK AG\11,710,522$1.1B1.47%
NORGES BANK9,686,029$888.0M1.22%
ACADIAN ASSET MANAGEMENT LLC9,096,779$833.9M1.14%
FMR LLC8,983,071$823.6M1.13%
GOLDMAN SACHS GROUP INC8,571,015$785.8M1.08%
Invesco Ltd.8,325,612$763.3M1.04%
First Eagle Investment Management, LLC8,205,699$752.3M1.03%

Institutional ownership by quarter

2023-092026-0684.8%
% of shares held by 13F filers
2023-092026-062,032
Number of 13F filers holding

Holder changes by quarter

QuarterHoldersOwnershipNewIncreasedReducedClosed
2026-06-302,03284.8%193732734101
2026-03-311,96584.8%202717705105
2025-12-311,89984.4%224594762128
2025-09-301,84884.0%143581754186
2025-06-301,92285.0%121643766120
2025-03-311,95185.7%158655780114
2024-12-311,93985.3%226638711165
2024-09-301,91484.7%18566868976
2024-06-301,82684.2%15962266983
2024-03-311,77685.2%158569716104
2023-12-311,74783.9%23156164585
2023-09-301,62683.7%102503670137

Schedule 13D / 13G filers

FiledFormFiler% of classShares
2026-04-29SCHEDULE 13GVanguard Capital Management7.5%60,404,276
2026-03-26SCHEDULE 13G/AThe Vanguard Group0.0%0
2025-02-07SCHEDULE 13G/AThe Vanguard Group10.1%82,189,533
Required above 5% of a class; 13G is the passive form.

ETFs with the largest holding

ETFWeight in fundHolding value
VITSX0.09%$2.2B
VTSAX0.09%$2.2B
VTI0.09%$2.2B
VSMPX0.09%$2.2B
VFFSX0.10%$1.8B
VOO0.10%$1.8B

Share structure

Shares outstanding797,173,000
Float748,353,965
Free float93.9%

Income statement

Fiscal years, USD
FY2021FY2022FY2023FY2024FY2025
Revenue$17.4B$18.0B$19.5B$20.1B$20.4B
Cost of revenue$7.1B$7.8B$8.2B$8.0B$8.1B
Gross profit$10.3B$10.2B$11.3B$12.1B$12.3B
R&D$307.0M$320.0M$343.0M$355.0M$0
SG&A$6.1B$6.2B$6.8B$7.8B$7.9B
Operating income$3.9B$3.6B$4.1B$4.4B$4.3B
EBITDA$3.8B$3.4B$4.2B$4.9B$4.0B
Pretax income$3.1B$2.7B$3.4B$4.0B$3.1B
Income tax$749.0M$693.0M$937.0M$907.0M$798.0M
Net income$2.2B$1.8B$2.3B$2.9B$2.1B
EPS, diluted$2.55$2.13$2.77$3.51$2.63
Diluted shares848.3M838.8M829.2M822.5M811.1M

Balance sheet

FY2021FY2022FY2023FY2024FY2025
Cash & short-term investments$832.0M$775.0M$966.0M$1.3B$1.3B
Receivables$1.3B$1.5B$1.6B$1.5B$1.7B
Inventory$1.7B$2.1B$1.9B$2.0B$2.0B
Total current assets$4.4B$5.1B$5.3B$5.3B$5.7B
PP&E, net$3.7B$4.3B$4.6B$4.4B$4.7B
Goodwill & intangibles$5.7B$5.3B$5.3B$5.0B$4.7B
Total assets$15.0B$15.7B$16.4B$16.0B$16.3B
Accounts payable$1.5B$1.6B$1.7B$1.8B$0
Total current liabilities$4.1B$4.0B$4.7B$5.8B$5.7B
Long-term debt$7.2B$8.7B$8.2B$7.3B$8.0B
Total liabilities$14.1B$14.9B$15.4B$15.5B$16.0B
Shareholders' equity$971.0M$806.0M$957.0M$544.0M$365.0M

Cash flow statement

Outflows are negative
FY2021FY2022FY2023FY2024FY2025
Net income$2.3B$2.0B$2.5B$3.0B$2.1B
Depreciation & amortization$556.0M$545.0M$567.0M$605.0M$630.0M
Stock-based compensation$135.0M$125.0M$122.0M$135.0M$0
Change in working capital−$197.0M−$726.0M$455.0M$344.0M$284.0M
Operating cash flow$3.3B$2.6B$3.7B$4.1B$4.2B
Capital expenditure−$567.0M−$696.0M−$705.0M−$561.0M−$564.0M
Free cash flow$2.8B$1.9B$3.0B$3.5B$3.6B
Investing cash flow−$592.0M−$1.6B−$742.0M−$534.0M−$817.0M
Net debt issued / repaid−$175.0M$1.6B−$314.0M−$408.0M−$456.0M
Buybacks−$1.3B−$1.3B−$1.1B−$1.7B−$1.2B
Dividends paid−$1.7B−$1.7B−$1.7B−$1.8B−$1.8B

Ratio history

Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end
FY2021FY2022FY2023FY2024FY2025
Gross margin59.6%56.9%58.2%60.5%60.1%
Operating margin22.8%20.8%21.6%22.6%21.3%
Net margin12.4%9.9%11.8%14.4%10.5%
FCF margin15.8%10.4%15.6%17.6%17.8%
ROE320.4%353.5%455.4%704.0%1,602.3%
ROIC39.6%31.1%34.9%46.8%47.5%
ROA14.0%11.6%14.3%17.8%13.2%
Debt / equity12.8623.1214.8840.15147.93
Interest coverage18.6x18.4x15.5x17.4x12.4x
Current ratio1.091.281.110.921.00
Revenue growth+5.8%+3.1%+8.3%+3.3%+1.4%
EPS growth−18.4%−16.5%+30.3%+26.0%−24.6%
P/E at year end30.3x34.3x27.3x25.3x29.8x
EV / EBITDA at year end19.0x20.8x16.9x16.7x17.8x
FCF yield at year end4.21%3.04%4.84%4.86%5.71%
Dividend payout77.5%94.7%76.0%61.9%85.5%

Revenue by segment

FY2021FY2022FY2023FY2024FY2025
Oral, Personal and Home Care$14.1B$14.3B$15.2B$15.6B$15.8B
Pet Nutrition$3.3B$3.7B$4.3B$4.5B$4.6B

Revenue by region · FY2025

Oral, Personal and Home Care$4.8B · 61%
Pet Nutrition$3.1B · 39%

Street estimates by fiscal year

Next report 2026-10-30 · consensus EPS $0.93 · these are analysts' numbers, not ours
Fiscal yearRevenue (mean)Revenue rangeEPS (mean)EPS rangeAnalystsP/E on mean EPS
2026$21.4B$21.1B – $21.6B$3.86$3.82 – $4.011124.4x
2027$22.1B$21.7B – $22.4B$4.08$4.01 – $4.171223.0x
2028$22.9B$22.4B – $23.5B$4.39$3.61 – $4.70621.5x

Reported vs expected, every quarter on file

ReportedEPS expectedEPS actualEPS surpriseRevenue expectedRevenue actualRevenue surprise
2026-07-31$0.95$0.99+4.5%$5.4B$5.4B+0.1%
2026-05-01$0.94$0.97+2.9%$5.2B$5.3B+2.1%
2026-01-30$0.91$0.95+4.2%$5.1B$5.2B+2.1%
2025-10-31$0.89$0.91+2.4%$5.1B$5.1B+0.1%
2025-08-01$0.90$0.92+2.6%$5.0B$5.1B+1.5%
2025-04-25$0.86$0.91+6.3%$4.9B$4.9B+0.9%
2025-01-31$0.90$0.91+1.1%$5.0B$4.9B−0.7%
2024-10-25$0.89$0.91+2.2%$5.0B$5.0B+0.5%
2024-07-26$0.87$0.91+4.6%$5.0B$5.1B+1.1%
2024-04-26$0.81$0.86+6.2%$5.0B$5.1B+2.1%
2024-01-26$0.85$0.87+2.4%$4.9B$5.0B+1.2%
2023-10-27$0.80$0.86+7.5%$4.8B$4.9B+2.0%
2023-07-28$0.75$0.77+2.7%$4.7B$4.8B+2.7%
2023-04-28$0.70$0.73+4.3%$4.6B$4.8B+4.1%
2023-01-27$0.77$0.770.0%$4.6B$4.6B+0.8%
2022-10-28$0.73$0.74+1.4%$4.5B$4.5B−0.4%
2022-07-29$0.71$0.72+1.4%$4.4B$4.5B+3.1%
2022-04-29$0.74$0.740.0%$4.4B$4.4B+0.0%
2022-01-28$0.79$0.790.0%$4.4B$4.4B−0.3%
2021-10-29$0.79$0.81+2.5%$4.4B$4.4B+0.3%
2021-07-30$0.80$0.800.0%$4.3B$4.3B0.0%
2021-04-30$0.79$0.80+1.3%$4.3B$4.3B+1.3%
2021-01-29$0.76$0.77+1.3%$4.3B$4.3B+1.3%
2020-10-30$0.70$0.79+12.9%$3.7B$4.2B+12.9%

Off-exchange (dark pool) volume, weekly

FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)
0.506-150.506-220.306-290.507-060.407-130.507-200.707-270.708-030.408-100.508-170.308-240.508-31
Week ofNotionalSharesTrades
2026-08-31$540.3M5,999,910111,424
2026-08-24$335.0M3,662,14390,951
2026-08-17$459.3M5,055,65791,826
2026-08-10$375.1M4,053,40989,041
2026-08-03$664.4M7,211,946123,558
2026-07-27$667.2M7,234,594124,395

Short-sale share of off-exchange volume

daily 20-day average
07-2310-1561.5%
DateShort shareShort volumeTotal volume
2026-10-1561.5%1,406,0612,285,352
2026-10-1458.8%1,050,1571,786,187
2026-10-1359.8%771,7141,291,470
2026-10-1246.7%567,3711,214,864
2026-10-0949.5%546,5671,103,677
2026-10-0866.6%875,5851,314,665
2026-10-0754.5%813,3271,491,891
2026-10-0661.2%764,8841,249,921
2026-10-0564.1%1,296,3182,020,863
2026-10-0250.3%885,0211,758,053
A daily flow measure from FINRA, not short interest.

Seasonality

Average return by calendar month
+0.7Jan+0.5Feb+1.3Mar+1.5Apr+0.6May+0.5Jun+0.6Jul-0.2Aug-0.0Sep+0.1Oct+2.7Nov+0.8Dec
MonthAvg returnUp yearsYears
Jan+0.7%40%20
Feb+0.5%60%20
Mar+1.3%71%21
Apr+1.5%70%20
May+0.6%55%20
Jun+0.5%55%20
Jul+0.6%60%20
Aug−0.2%50%20
Sep−0.0%45%20
Oct+0.1%60%20
Nov+2.7%80%20
Dec+0.8%50%20
History, not a forecast.

Indicators

as of 2026-10-16
RSI 1473.1
MFI76.9
ADX26.5
Stochastic %K / %D88.2 / 89.8
Williams %R-11.0
CCI192
TSI / signal18.3 / -4.0
Chaikin money flow-0.04
ATR$1.68
Bollinger width12.4%
Volume vs 20-day avg0.86x
SupertrendUp

Moving averages and bands

level (price vs level)
SMA 20$87.71 (+7.3%)
SMA 50$89.16 (+5.6%)
SMA 200$88.91 (+5.8%)
EMA 21$89.00 (+5.7%)
EMA 50$89.00 (+5.7%)
EMA 200$88.40 (+6.5%)
Bollinger upper$93.17 (+1.0%)
Bollinger lower$82.25 (+14.4%)
Parabolic SAR$87.72 (+7.3%)
Open the live chart, 110+ indicators

About Colgate-Palmolive Company

Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division encompasses a broad array of offerings, spanning oral hygiene (e.g., toothpastes, toothbrushes, mouthwashes), personal care (e.g., bar and liquid soaps, shower gels, shampoos, conditioners, deodorants, antiperspirants, skin health items), and home care solutions (e.g., dishwashing detergents, fabric conditioners, household cleaners). These products are distributed through various channels, including traditional and online retailers, wholesalers, and distributors, under well-known brand names such as Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly. Furthermore, this segment supplies specialized pharmaceutical products to dentists and other professionals in oral healthcare. Conversely, the Pet Nutrition segment focuses on providing specialized pet food. This includes everyday nutritional options marketed under the Hill's Science Diet brand, as well as therapeutic diets designed to assist in managing various health conditions in dogs and cats, sold under the Hill's Prescription Diet brand. Distribution for these pet nutrition items occurs via pet supply stores, veterinary clinics, and online retail platforms. Established in 1806, Colgate-Palmolive Company maintains its corporate headquarters in New York, New York.

https://www.colgatepalmolive.com

Key executives

NameTitlePayBorn
Noel R. WallaceChairman, Chief Executive Officer & President$4.8M1964
Shane GrantChief Operating Officer of Americas$3.1M1975
Stanley J. SutulaChief Financial Officer$2.5M1966
Panagiotis TsourapasCOO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health$2.2M1965
Dana BoldenChief Communications Officer—1968
Eutychus KaruruExecutive Vice President of Internal Audit & Compliance——
John FaucherChief Investor Relations Officer and Executive Vice President of M&A——
Ram RaghavanChief Marketing Officer—1973

Executive pay, latest proxy

ExecutiveYearSalaryStock awardsIncentiveTotal
Noel Wallace Chairman, President and Chief Executive Officer2025$1.5M$8.0M$2.5M$16.5M
Shane Grant Chief Operating Officer, Americas2025$592,308$8.4M$1.2M$11.9M
Stanley J. Sutula III Chief Financial Officer2025$1.1M$2.1M$1.2M$5.7M
Panagiotis Tsourapas Chief Operating Officer, Eur., APac, Afr/Eur, Skin and Global Cust. Dev.2025$1.0M$1.3M$871,760$4.1M
Jennifer M. Daniels Chief Legal Officer and Secretary2025$952,706$1.3M$718,393$3.8M

Employees

34k201834k201934k202034k202134k202234k202334k202434k2025

Dividends

Ex-dateAmountPaid
2026-10-20$0.532026-11-13
2026-07-20$0.532026-08-14
2026-04-20$0.532026-05-15
2026-01-21$0.522026-02-13
2025-10-17$0.522025-11-14
2025-07-18$0.522025-08-15
2025-04-17$0.522025-05-15
2025-01-21$0.52025-02-14

Moat model

Narrow · Cost Advantage · 2026-06-30
Cost advantage75
Intangibles51
Switching costs54
Network effect50
Efficient scale75
Our component scores (0-100) and overall 60.0; a model of the business, not a call on the stock.
InsiderStreet reports findings from filings and market data. Nothing on this page is a recommendation to buy or sell.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms